Technology Networks3d
Why Ritalin Helps Improve Focus in Some More Than Others
Our brain cells have different types of chemical receptors that work together to produce optimal performance of brain ...
Key brain differences can explain why Ritalin helps improve focus in some more than others
Nearly 16 million American adults have been diagnosed with attention deficit hyperactivity disorder (ADHD), but evidence ...
Technology Networks2d
New Drug Reduces ADHD Symptoms by 45%
Solriamfetol, a new treatment for ADHD, showed a 45% reduction in symptoms in a Phase 3 trial. This treatment targets ...
Treatment for Parkinson’s disease and restless leg syndrome is linked with risky behaviour – here’s what you need to know
Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or ...
India Today on MSN2d
Are daily habits draining your motivation? A neuroscientist explains
When dopamine levels are artificially increased too often, such as through excessive social media use or junk food ...
GEN - Genetic Engineering and Biotechnology News8d
GLP-1 Drugs Effectiveness Reduced by Neurons That Control Overeating
Researchers identified how a brain circuit involving dopamine and GLP-1 receptor impact palatability and hedonic eating.
Vanda Pharmaceuticals Announces the Submission of an NDA to the FDA for Bysanti™ for the Treatments of Acute Bipolar I Disorder and Schizophrenia
Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that a New Drug Application (NDA) was submitted to the U.S.